|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.535
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.529
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.517
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.495
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.468
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.447
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.405
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.403
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.371
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.371
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.370
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.365
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.362
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.361
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.359
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.353
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.348
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.339
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.305
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.271
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.267
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.262
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.259
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.258
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.255
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.250
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.230
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.224
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.223
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.222
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.218
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.217
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.217
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.207
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.205
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.202
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.196
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.193
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.189
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.189
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.186
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.184
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.183
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.181
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.180
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.180
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.179
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.177
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.176
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.173
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.173
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.167
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.164
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.164
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.162
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.159
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.159
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.154
|
|
|
|
regulation of urine volume
|
GO:0035809 |
6 |
0.149
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.149
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.145
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.144
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.143
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.142
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.142
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.142
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.142
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.141
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.141
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.140
|
|
|
|
sphingosine 1 phosphate signaling pathway
|
GO:0003376 |
3 |
0.139
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.139
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.135
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.135
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.134
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.132
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.130
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.130
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.129
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.128
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.127
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.124
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.122
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.122
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.122
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.120
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.118
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.118
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.117
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.117
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.116
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.116
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.116
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.115
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.115
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.115
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.114
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.114
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.113
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.111
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.111
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.111
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.110
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.110
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.107
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.105
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.102
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.102
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.102
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.102
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.101
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.100
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.099
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.099
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.097
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.097
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.096
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.095
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.095
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.094
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.093
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.093
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.092
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.091
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.090
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.090
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.088
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.087
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
20 |
0.086
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.085
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.085
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.085
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.085
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.084
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.084
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.083
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.083
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.083
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.083
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.082
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.082
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.082
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.082
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.082
|
|
|
|
alanine transport
|
GO:0032328 |
4 |
0.081
|
|
|
|
positive regulation of fibroblast growth factor receptor signaling pathway
|
GO:0045743 |
3 |
0.080
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.080
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.080
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.079
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.079
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.078
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.078
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.078
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.078
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.078
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.078
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.077
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.077
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.077
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.077
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.076
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.076
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.076
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.074
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.074
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.073
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.073
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.073
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.073
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.073
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.072
|
|
|
|
lens epithelial cell proliferation
|
GO:0097166 |
1 |
0.072
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.072
|
|
|
|
cardiac muscle tissue growth involved in heart morphogenesis
|
GO:0003245 |
1 |
0.071
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.071
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.071
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.070
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.070
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.070
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.070
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.069
|
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.069
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.069
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.069
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.069
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.068
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.068
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.068
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.068
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.067
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.067
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.066
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.066
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.065
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.065
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.065
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.065
|
Zebrafish |
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.064
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.064
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.064
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.062
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.062
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.061
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.061
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.061
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.061
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.061
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.060
|
|
|
|
regulation of adrenergic receptor signaling pathway
|
GO:0071877 |
4 |
0.060
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.060
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.060
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.060
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.060
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.059
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.059
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.058
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.058
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.058
|
|
|
|
central nervous system projection neuron axonogenesis
|
GO:0021952 |
21 |
0.057
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.057
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.057
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.057
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.057
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.057
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.056
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.056
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.056
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.056
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.056
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.055
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.055
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.055
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.055
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.055
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.054
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.054
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.054
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.054
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.054
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.054
|
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.053
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
26 |
0.053
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.053
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.053
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.053
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.052
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902238 |
1 |
0.052
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.052
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.052
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.051
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.051
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.051
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.051
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.051
|
|
|
|
regulation of osteoblast proliferation
|
GO:0033688 |
15 |
0.051
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.050
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.050
|
|
|
|
positive regulation of urine volume
|
GO:0035810 |
6 |
0.049
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.049
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.049
|
|
|
|
atrial septum primum morphogenesis
|
GO:0003289 |
3 |
0.049
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.049
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.049
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.049
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.048
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.048
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.048
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.048
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1990127 |
1 |
0.048
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.048
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.048
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.048
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.047
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.047
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.046
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.046
|
Zebrafish |
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.046
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.046
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.046
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.046
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.045
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.045
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.045
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.045
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.045
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.045
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.044
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.044
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.044
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.044
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
32 |
0.044
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.044
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.044
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.044
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.044
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.044
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.044
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.044
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.044
|
|
|
|
monocyte extravasation
|
GO:0035696 |
2 |
0.044
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.044
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.044
|
|
|
|
regulation of bone remodeling
|
GO:0046850 |
28 |
0.043
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.043
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.043
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.043
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.043
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.043
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.043
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.042
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.042
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.042
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.042
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.042
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.042
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.042
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.042
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.041
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.041
|
|
|
|
phospholipid transfer to membrane
|
GO:0006649 |
2 |
0.041
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.041
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.041
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.041
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.041
|
|
|
|
regulation of vascular smooth muscle contraction
|
GO:0003056 |
1 |
0.040
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.040
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.040
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.040
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.040
|
|
|
|
male sex determination
|
GO:0030238 |
14 |
0.039
|
|
|
|
growth involved in heart morphogenesis
|
GO:0003241 |
4 |
0.039
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.039
|
|
|
|
regulation of camp mediated signaling
|
GO:0043949 |
7 |
0.039
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.039
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.039
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.039
|
|
|
|
semaphorin plexin signaling pathway involved in bone trabecula morphogenesis
|
GO:1900220 |
2 |
0.039
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.038
|
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
18 |
0.038
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.038
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.038
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.038
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.038
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.038
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.038
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.038
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.038
|
|
|
|
postganglionic parasympathetic nervous system development
|
GO:0021784 |
2 |
0.037
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.037
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.037
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.037
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.037
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.037
|
|
|
|
positive regulation of glutamate secretion
|
GO:0014049 |
2 |
0.037
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.037
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.037
|
|
|
|
semaphorin plexin signaling pathway involved in axon guidance
|
GO:1902287 |
6 |
0.037
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.037
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.036
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.036
|
|
|
|
inner cell mass cellular morphogenesis
|
GO:0001828 |
1 |
0.036
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.036
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.035
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.035
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.035
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.035
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
13 |
0.035
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.035
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.035
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.035
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.035
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.035
|
|
|
|
glucan metabolic process
|
GO:0044042 |
32 |
0.035
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.035
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.034
|
|
|
|
negative regulation of ras protein signal transduction
|
GO:0046580 |
18 |
0.034
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.034
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.034
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.034
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.034
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.034
|
|
|
|
regulation of monocyte extravasation
|
GO:2000437 |
2 |
0.034
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.034
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.034
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.034
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.033
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.033
|
Zebrafish |
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.033
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.033
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.033
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.033
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.033
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.033
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.033
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.033
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.033
|
|
|
|
gonadotrophin releasing hormone neuronal migration to the hypothalamus
|
GO:0021828 |
3 |
0.033
|
|
|
|
regulation of g protein coupled receptor protein signaling pathway
|
GO:0008277 |
37 |
0.033
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.033
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.033
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.033
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.033
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.032
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.032
|
|
|
|
n acetylglucosamine metabolic process
|
GO:0006044 |
3 |
0.032
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.032
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.032
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.032
|
|
|
|
regulation of bone trabecula formation
|
GO:1900154 |
1 |
0.032
|
|
|
|
cerebellar granule cell precursor tangential migration
|
GO:0021935 |
1 |
0.032
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.032
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.032
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.032
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.032
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.032
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.031
|
|
|
|
regulation of glutamate secretion
|
GO:0014048 |
3 |
0.031
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.031
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.031
|
|
|
|
osteoblast development
|
GO:0002076 |
17 |
0.031
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.031
|
|
|
|
regulation of interleukin 1 alpha production
|
GO:0032650 |
4 |
0.031
|
|
|
|
positive regulation of dopamine uptake involved in synaptic transmission
|
GO:0051586 |
2 |
0.031
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.031
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.031
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.031
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.031
|
|
|
|
interleukin 1 alpha secretion
|
GO:0050703 |
3 |
0.030
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.030
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.030
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.030
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.030
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.030
|
|
|
|
positive regulation of protein autophosphorylation
|
GO:0031954 |
4 |
0.030
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.030
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.030
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.030
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
26 |
0.030
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.030
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.030
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.030
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.030
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.030
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.029
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.029
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.029
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.029
|
|
|
|
regulation of glomerulus development
|
GO:0090192 |
6 |
0.029
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.029
|
|
|
|
positive regulation of cd8 positive alpha beta t cell extravasation
|
GO:2000451 |
2 |
0.029
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.029
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.029
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.029
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.029
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.028
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.028
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.028
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.028
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.028
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.028
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.028
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.028
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.028
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.028
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.028
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.028
|
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.028
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.028
|
|
|
|
sertoli cell differentiation
|
GO:0060008 |
18 |
0.028
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.027
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.027
|
|
|
|
sympathetic neuron projection guidance
|
GO:0097491 |
4 |
0.027
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.027
|
|
|
|
central nervous system neuron axonogenesis
|
GO:0021955 |
28 |
0.027
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.027
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.027
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.027
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.027
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.027
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.027
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.027
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.027
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.027
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.027
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.027
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.027
|
|
